AVEVA, a global leader in industrial software, driving digital transformation and sustainability, today announced it has won the 2025 Microsoft Manufacturing Partner of the Year Award. The company was ...
AVEVA, a global leader in industrial software, driving digital transformation and sustainability, is setting a new standard for the industrial digital twin by converging all data onto CONNECT ...
Computer-aided design, or cad software, has emerged as one of the most disruptive technologies reshaping how industries envision, prototype, and manufacture products. Once reserved for specialist ...
Jesus Hernandez highlights the company’s role in advancing sustainable energy Aveva Jesus Hernandez, SVP EMEA of AVEVA In an exclusive interview, Jesus Hernandez, SVP of EMEA, AVEVA, explains how ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
Cairo, Egypt - AVEVA, a global leader in industrial software, driving digital transformation and sustainability will host AVEVA Day Egypt on 1st October at Triumph Luxury Hotel, Cairo, Egypt. The ...
AVEVA, a global leader in industrial software driving innovation and sustainability, has launched a documentary titled ‘Radical Collaboration’ in partnership with CNBC, exploring how digitalisation ...
This photo taken on Feb. 27, 2024 shows a digital manufacturing plant for children's garment at Zhili town of Huzhou city, East China's Zhejiang province. Xu Yu/XINHUA Industrial software developer ...
As Indian enterprises embrace the fourth industrial revolution (Industry 4.0), industrial intelligence—the convergence of AI, IoT, robotics, and big data analytics—is driving a profound shift toward ...
Industrial software developer Aveva has ramped up efforts to increase its research and development investment in China, while also deepening its cooperation with local partners, to bolster the digital ...
Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% patch, a non-opioid topical treatment for post-herpetic neuralgia. The generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results